Hematology

The field of hematology continues to expand as the number of ancillary studies for prognosis and classification of hematologic malignancies continues to increase. Test selection, technical quality and practical integration of the data are key elements to accurate diagnosis and prognostication of hematolymphoid malignancies. Pathology, Inc. recognizes these demanding needs and utilizes the latest state-of-the-art technologies and expertise to ensure that complete and concise information is provided to meet today’s unique treatment planning requirements. Our goal is to help provide the best outcomes for patients faced with hematologic disease.